The other question is given Neuren’s drug was recently approved my main question is given Neuren has been granted ODD for the Rett syndrome does this give them 7 year marketing exclusivity or not? The FDA approval for Daybue didn’t mention exclusivity granted for their drug (they got paediatric rare drug PRV) so I am guessing we can also stand to get marketing approval if we fly past phase 3.
https://data-api.marketindex.com.au/api/v1/announcements/XASX:NEU:2A1436933/pdf/inline/fda-approves-daybue-the-first-treatment-for-rett-syndrome
- Forums
- ASX - By Stock
- Ann: Trading Halt
The other question is given Neuren’s drug was recently approved...
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NTI (ASX) to my watchlist
(20min delay)
|
|||||
Last
7.5¢ |
Change
-0.002(2.60%) |
Mkt cap ! $76.30M |
Open | High | Low | Value | Volume |
7.7¢ | 7.7¢ | 7.5¢ | $68.50K | 897.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 131736 | 7.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.8¢ | 70251 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 131736 | 0.075 |
1 | 7432 | 0.074 |
3 | 249651 | 0.073 |
3 | 71646 | 0.072 |
3 | 866408 | 0.071 |
Price($) | Vol. | No. |
---|---|---|
0.078 | 70251 | 3 |
0.079 | 451112 | 1 |
0.080 | 754857 | 3 |
0.081 | 48000 | 1 |
0.082 | 50000 | 1 |
Last trade - 16.10pm 15/05/2024 (20 minute delay) ? |
|
|||||
Last
7.6¢ |
  |
Change
-0.002 ( 0.00 %) |
|||
Open | High | Low | Volume | ||
7.6¢ | 7.7¢ | 7.5¢ | 172072 | ||
Last updated 15.40pm 15/05/2024 ? |
Featured News
NTI (ASX) Chart |
The Watchlist
SS1
SUN SILVER LIMITED
Gerard O’Donovan, Executive Director
Gerard O’Donovan
Executive Director
SPONSORED BY The Market Online